Christopher O.

Critic
DISC Type : C

Principal Scientist at Capsida Biotherapeutics

Los Angeles, California, United States

Overview

Christopher O. is a Principal Scientist at Capsida Biotherapeutics specializing in AAV-based gene therapy for CNS and cardiac indications. With a Ph. D. from the University of Rhode Island, he leads discovery and IND-enabling programs by integrating in vivo pharmacology, disease modeling, and next-generation viral vectors.


He was a featured speaker at the 5th Annual CNS Drug Delivery Summit, presenting new preclinical data on CNS-targeted capsids.

Personality Overview

ROI Driven

Objective Thinker

Negotiator

They don’t appreciate bells and whistles unless backed by data.  They like to take decisions independently and do not seek others' support often. They prefer to analyze logically and value objective facts over emotions.

Topics They Care About

CNS Drug Delivery
Presented new data on CNS-targeted capsids and other preclinical studies at the 5th Annual CNS Drug Delivery Summit in late 2023.
AAV Gene Therapy
Leads discovery and early translational research for AAV-based gene therapy programs targeting central nervous system and cardiac diseases.
Translational Research
His work focuses on advancing next-generation viral vectors from discovery through IND-enabling programs, bridging the gap between lab research and clinical application.

Media Appearances

Christopher has no verified media appearances

Work History

1-2024 - 11-2025
Principal Scientist at Capsida Biotherapeutics
1-2022 - 12-2023
Senior Scientist at Capsida Biotherapeutics
10-2020 - 1-2022
Scientist II at Capsida Biotherapeutics
8-2014 - 8-2020
Postdoctoral Scholar at David Geffen School of Medicine at UCLA
8-2010 - 8-2014
Graduate Research Assistant at University of Rhode Island

Education

8-2014 - 8-2020
Postdoctoral Scholar from David Geffen School of Medicine at UCLA
2010 - 2014
Doctor of Philosophy (Ph.D.) from University of Rhode Island

More Information

Social Presence :

Prographics :

Exp : 17 Location : Los Angeles, California, United States Job Level : N/A Designation : Principal Scientist at Capsida Biotherapeutics
URL has been copied!

Insights For Selling To Christopher

During A Call Or A Meeting

DO's

  • Tell them what ROI they can expect
  • Don’t forget to mention how you compare to competition on both features and pricing
  • Leverage facts and figures wherever possible; use percentages, numbers etc.

DONT's

  • Don’t try too hard to build a relationship with them
  • Make extra effort to not seem pushy or confrontational
  • Avoid pushing them too much to involve other stakeholders unless it is critical

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Christopher is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Christopher

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Christopher move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Christopher take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Christopher

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.